SEPA III: The Effectiveness Trial

HIV Prevention Clinical Trial

— SEPA III  

Official title:

SEPA III: The Effectiveness Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02405481
• Other study ID #: 20120037
• Status: Completed
• Phase: N/A
• Start date: June 2013
• Est. completion date: March 2016

Study information

• Verified date: May 2018
• Source: University of Miami
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study evaluates the effectiveness of SEPA (Salud, Educacion, Prevencion y Autocuidado; Health, Education, Prevention and Self-Care) to increase HIV prevention behaviors and to reduce the incidence of STIs for Hispanic women when delivered in a real-world setting by community agency personnel. The study recruits Hispanic women between the ages of 18 and 50 who are sexually active and are randomized to either SEPA or a Wait-List Control condition.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 320
• Est. completion date: March 2016
• Est. primary completion date: March 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• Hispanic Women,

• 18 to 50 years old,

• Sexually active in the past three months

Exclusion Criteria:

• Non-Hispanic,

• younger than 18,

• older than 50,

• not sexually active

Related Conditions & MeSH terms

• HIV Prevention

Intervention

Behavioral:
• SEPA III

Locations

Country	Name	City	State
United States	University of Miami	Miami	Florida

Sponsors (1)

Lead Sponsor	Collaborator
University of Miami

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Condom Use		1 year